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with patients genotypes .These results showed that FAS1377G/A
and FAS -670 A/G gene polymorphisms had a strong linkage disequi-
librium with ( p value <0.001).
Discussion: Several polymorphism sites have been identified to
influence the development of breast cancer. Death receptor activation
triggers extrinsic apoptotic pathways, which in some cell types may
be enough to carry apoptosis. Several previous researches concen-
trated on the association between different gene polymorphisms
within cell death pathways and the risk of developing malignancies
and developing cancers. FAS polymorphisms may play different, con-
text-dependent roles in cancer Crew et al., found no association
between breast cancer and FAS -1377 G/A, FAS-670 G/A polymor-
phisms. On the other hand, Zhang et al., reported an important asso-
ciation between FAS 1377G/A gene polymorphism and risk of breast
cancer, but they reported no association between FAS -670 G/A and
breast cancer risk.
Hashemi et al., mentioned that the FAS-1377 G/A did not affect
the risk of breast cancer, while FAS -670 G/A gene polymorphism
was risk factor. Krippl et al., in a study of 500 breast cancer
patients and 500 controls in a Caucasian population in Austria,
found a significant association between FAS-1377G/A and
increased risk of breast cancer, but they reported no associations
with FAS -670G/ A.
Our study indicates the lack of association between
FAS1377G>A and FAS -670 A/G gene polymorphisms and risk
of breast cancer. Also, a main linkage disequilibrium is found
betweenFAS1377G/A and FAS -670 A/G gene polymorphisms in
case and control groups.
One of the limitation in our study is small sample size.
While there have been current discussions on the influence of var-
ious polymorphisms within the signaling molecules relevant to cell
death pathways, and cancer formation, this work has proved its worth.
Also, we suggest to study the other candidate gene polymorphism
which may be beneficial for identifying the factors involved in breast
cancer.
Keywords: Breast cancer, FAS1377G>A, FAS -670 A/G, Link-
age disequilibrium, Gene polymorphism
Gene expression (mRNA) profile of apoptotic related genes
in MCF-7 and T47D breast cancer cells treated by cisplatin
Mohammad Javad Mokhtari a, Fatemeh Koohpeima b,*,
Hojjat Naderi-Meshkin c, Hadi Mohammadi d
a Department of Biology, Zarghan Branch, Islamic Azad University,
Zarghan, Iran b Department of Operative Dentistry, School of
Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran
c Stem Cells and Regenerative Medicine Research Department,
ACECR-Khorasan Razavi Branch, Mashhad, Iran d Young




Introduction: Cisplatin is widely used for the treatment of
many malignancies. The activity of cisplatin is thought to be a
result of formation of inter- and intra-strand DNA crosslinks. How-
ever, the events leading to apoptotic cell death after cisplatin treat-
ment are not well understood and may involve regulation of the
expression of multiple genes. BCL2 family represents major regu-
lators of apoptosis. The balance of cell death protectors and
inducers in the BCL2 family of proteins has been proposed as acommon determinant of the susceptibility of cells to apoptotic
cell death induced by various stimuli. In the present study, we com-
pared the anticancer potential of cisplatin on the MCF-7 and T47D
breast cancer cell lines. The effect of cisplatin on tumor cell apop-
tosis induction as well as on BCL2L12, BAX and BAD expression
was studied.
Materials and methods: Cell culture and drug treatment:
MCF-7 and T47D cells were maintained in RPMI 1640 supplemented
with 10% fetal bovine serum, 2 mM glutamine and 1% penicillin e
streptomycin under standard culture conditions. Cells were treated
with different concentrations of cisplatin for 24 h.
Cytotoxicity assay: The cytotoxicity of cisplatin was assessed by
the MTT assay. Cells were seeded on 96-well micro plates at a density
of 1104 cells per well in 100 ml of RPMI 1640 medium. After incu-
bation at 37C in a humidified incubator for 24 h, cells were exposed
to various concentrations of cisplatin for 24 h. After incubation, 10 ml
of MTT solution (5 mg/ml in PBS) was added to the cells. Cells were
incubated at 37C for 3 h and the optical density was measured using
a microplate reader at 540 nm.
RNA extraction and cDNA synthesis: Total RNA was isolated
from cells using RNX-Plus Solution (CinaGen, IRAN). RNA sam-
ples with the A260/A230 and A260/A280 ratios above 1.7 were
selected for cDNA synthesis. cDNA synthesis was performed
using Revert AidTMFirst Strand cDNA Synthesis Kit (Fermentas,
USA).
Primer design: Primers were designed using primer express soft-
ware v.3.0 (Applied Biosystems, USA). Synthesis of these primers
was performed by Bioneer, South Korea.
Real-time RT-PCR: Power SYBR Green PCR Master Mix
(Applied Biosystems, Warrington, UK) was employed to perform
quantitative PCR on the Rotor-Gene 6000 (Corbett Research, Aus-
tralia) applying the following thermal-cycling conditions: 10min at
95C (1 repeat) as first denaturation and Hot-start enzyme activation,
followed by 40 cycles at 95C for 15s and 60C for 1 min. Each com-
plete amplification stage was followed by a melting stage; at 95C for
15s, 60C for 30s and 95C for 15s. The PCR amplification was per-
formed in 20 ml reaction containing 10 ml Power SYBR Green PCR
Master Mix (2x), 0.6 ml Forward primer (0.4mM), 0.6 ml Reverse pri-
mer (0.4 mM), 5ml first-strand cDNA (100 ng) and 3.8 ml double-dis-
tillated water. Calculation of the gene expression was carried out
using comparative threshold cycle. The mean threshold cycle was
obtained from triplicate amplifications during the exponential phase.
Then target /control gene expression ratios were calculated by 2 -DDCt
formula.
Statistical analysis: The P-value of <0.05 was considered statisti-
cally significant for student's t-test analysis.
Result: In vitro toxicity and IC50 determination: The in vitro
anticancer cytotoxic activity of cisplatin on MCF-7 and T47D cells,
expressed as % cell viability, is shown in Fig. 1. The IC50 of cisplatin,
for MCF-7 and T47D cell lines were calculated to be 47.672mM and
43.694 mM, respectively.
BCL2L12, BAX, BAD mRNA expression after cisplatin
exposure: Alterations in gene expression were evaluated in
MCF-7 and T47D cells treated with 47.672 mM and 43.694 mM
of cisplatin, respectively. Treatment of MCF-7 cells with cisplatin,
resulted in the up regulation of the BAX mRNA levels. However,
we found no significant change in BCL2L12 and BAD mRNA
expression levels. In the case of T47D cells treated by cisplatin,
we observed up regulation of the BAX and BCL2L12 mRNA lev-
els. However we found no significant change in the BAD mRNA
levels.
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proteins. The ratio between pro- and anti-apoptotic members, their
three-dimensional conformation and their subcellular localization
constitute major determinants of the evolution of cells towards life
or death. Many researchers showed that cisplatin down regulated
BCL2 and BCL2L12 mRNA level in MCF-7 cell line. Other studies
showed that BCL2, BCL-XL, BAD and BAX were differentially regu-
lated by cisplatin. We showed that the cytotoxic effect of cisplatin
increased in a dose-dependent manner. The gene expression levels
in the two cancer cells were found to be similar in relation to BAD
and BAX mRNA expression whereas significant different was
observed on the BCL2L12. Our results show that selective activation
of BAX is a key event for the promotion of mitochondrial membrane
permeabilization by cisplatin in MCF-7 and T47D cells. MCF-7 and
T47D cells demonstrated no statistically significant BAD response to
cisplatin treatment at the mRNA level. BCL2L12 is a newly identified
member of BCL2 family. Treatment of T47D cells with cisplatin for
24 h resulted in the increase of the BCL2L12 mRNA levels. However,
we do not observe alteration in BCL2L12 mRNA expression levels in
MCF-7 cells. Therefore, BCL2L12 can also function distinctly in dif-
ferent cell types. By focusing on mRNA levels of apoptotic related
genes in response to cisplatin treatment in MCF-7 and T47D cell
lines, we provide evidence that the pro-apoptotic effects of cisplatin
in breast cancer are likely mediated through the up regulation of BAX.
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Fig. 1. Cytotoxiciy of cisplatin on MCF-7 and T47D cells. Results are
expressed as a percentage of viability compared to control and are presented
as mean±SD from at least three independent experiments. At concentrations
of 3.125, 6.25, 12.5, 25, 50 and 100 mM of cisplatin, T47D cell viability
was reduced to 96±3.40% (p<0.05), 85.75±6.29% (P<0.001),
84.00±12.12% (P<0.001), 67.16±12.12% (P<0.001), 35.66±3.30%
(P<0.001) and 30.5±2.51% (P<0.001), respectively. At the same concentra-
tions of cisplatin, T47D cell viability was reduced to 93.86±7.35% (difference
not significant, p˃0.05), 75.62±7.61% (P<0.01), 62.53±5.36% (P<0.01),
53.70±6.52% (P<0.01), 52.57±2.75% (P<0.001) and 40.41±5.66%
(P<0.001), respectively.
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Introduction: Inflammation is a coordinated process that occurs
following injury and various types of cells are involved in this proc-
ess. After inflammation, a series of inflammatory responses including
the leukocyte penetration and release of inflammatory and anti-
inflammatory mediators occurs. This action is done in order to relieve
inflammation and prevent chronic inflammation. Because, chronic
inflammatory diseases can lead to cancer, thus inhibiting inflamma-
tion can be effective in preventing cancer. Due to the side effects
of some anti-inflammatory drugs recently attention has been focused
to the use of natural products to suppress inflammation process. Sea
cucumbers have some bioactive compounds such as triterpene glyco-
sides (saponins), polysaccharides, glycosaminoglycan (GAGs), pepti-
des, sterols and chondroitin sulfates. Saponins are secondary
metabolites that were first identified in plants and later their existence
was confirmed in some marine animals including sea cucumbers.
These compounds have a wide spectrum of pharmacological and
health effects. Several studies have confirmed the role of saponins
extracted from various sources in the prevention of inflammation
but there is no information about anti-inflammatory effect of saponin
extracted from native sea cucumbers of Iran (Holothuria leucospi-
lota). This study was conducted to evaluate the cytotoxicity and
anti-inflammatory effects of Holothuria leucospilota sea cucumber
saponin on A549 cell line.
Materials and methods: Cell line: A549 cell line was purchased
from cell bank of Tehran, Iran. Appropriate conditions for the culti-
vation of these cells was RPMI supplemented with FBS (10 %) and
antibiotic (1 %), temperature of 37  C, humidified atmosphere and
5% CO2.
Cell proliferation assay: The monolayer cells was trypsinized
and seeded to 96 culture plate in a FBS-free medium. After 24 the
cells were exposed with various doses of saponin that dissolved in
fresh FBS-free RPMI medium for 24, 48 and 72 h. then, MTT dye
was added and incubated for 4 hours. The MTT solution was removed
and DMSO was added and finally the absorbance was measured with
a spectrophotometer at 570 nm.
Real time PCR assay: The alteration in the mRNA expression
of IL-1b was examined by Real Time PCR. Total RNA were iso-
lated from the cells (treated and untreated) using High Pure
RNA Isolation kit (Roche, Germany) and cDNA was synthesized
by Fermentase kit according to the manufacturer's protocol. Real-
time PCR analysis were done by reaction PCR containing SYBR
Green, cDNA, appropriate primer and water on Bio-Rad CFX96
system.
Result: Cell viability assay: Figure 1 exhibited that saponin
inhibited cell proliferative in concentration and time dependent man-
ners. IC50 values for saponin 48 h after treatment was about 0.5 mg/
ml.
Real time PCR: The Real-time- PCR analysis showed that the
expression of IL-1b was reduced as a pro-inflammatory gene. The
expression of this gene was reduced from 6.56 in untreated cells to
1.48 in treated cells.
Discussion: Saponins are the bioactive compounds that found in
sea cucumber and these compounds have a different biological char-
acteristics based on a variety of their structures. One of the most
important features of saponins is their cytotoxicity effects and in
various studies, cytotoxic properties of different saponins such as
ginsenoside on prostate cancer cells (LNCaP) with IC50: 650
mM, three saponins extracted from Nematostylis anthophylla on
